BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 29250809)

  • 21. The Ubiquitin-Proteasome System Does Not Regulate the Degradation of Porcine β-Microseminoprotein during Sperm Capacitation.
    Tumova L; Zigo M; Sutovsky P; Sedmikova M; Postlerova P
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32532042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic and transcriptomic profiling of Pten gene-knockout mouse model of prostate cancer.
    Zhang J; Kim S; Li L; Kemp CJ; Jiang C; Lü J
    Prostate; 2020 May; 80(7):588-605. PubMed ID: 32162714
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An RNAi Screen for Genes Required for Growth of
    Rotelli MD; Bolling AM; Killion AW; Weinberg AJ; Dixon MJ; Calvi BR
    G3 (Bethesda); 2019 Oct; 9(10):3087-3100. PubMed ID: 31387856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoreactivity for prostate specific antigen and Ki67 differentiates subgroups of prostate cancer related to outcome.
    Hammarsten P; Josefsson A; Thysell E; Lundholm M; Hägglöf C; Iglesias-Gato D; Flores-Morales A; Stattin P; Egevad L; Granfors T; Wikström P; Bergh A
    Mod Pathol; 2019 Sep; 32(9):1310-1319. PubMed ID: 30980038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microseminoprotein-Beta Expression in Different Stages of Prostate Cancer.
    Sjöblom L; Saramäki O; Annala M; Leinonen K; Nättinen J; Tolonen T; Wahlfors T; Nykter M; Bova GS; Schleutker J; Tammela TL; Lilja H; Visakorpi T
    PLoS One; 2016; 11(3):e0150241. PubMed ID: 26939004
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.
    Whitaker HC; Kote-Jarai Z; Ross-Adams H; Warren AY; Burge J; George A; Bancroft E; Jhavar S; Leongamornlert D; Tymrakiewicz M; Saunders E; Page E; Mitra A; Mitchell G; Lindeman GJ; Evans DG; Blanco I; Mercer C; Rubinstein WS; Clowes V; Douglas F; Hodgson S; Walker L; Donaldson A; Izatt L; Dorkins H; Male A; Tucker K; Stapleton A; Lam J; Kirk J; Lilja H; Easton D; ; ; ; Cooper C; Eeles R; Neal DE
    PLoS One; 2010 Oct; 5(10):e13363. PubMed ID: 20967219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer induces C/EBPβ expression in surrounding epithelial cells which relates to tumor aggressiveness and patient outcome.
    Adamo H; Hammarsten P; Hägglöf C; Dahl Scherdin T; Egevad L; Stattin P; Halin Bergström S; Bergh A
    Prostate; 2019 Apr; 79(5):435-445. PubMed ID: 30536410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
    Dahlman A; Rexhepaj E; Brennan DJ; Gallagher WM; Gaber A; Lindgren A; Jirström K; Bjartell A
    Mod Pathol; 2011 May; 24(5):708-19. PubMed ID: 21240253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate tumors downregulate microseminoprotein-beta (MSMB) in the surrounding benign prostate epithelium and this response is associated with tumor aggressiveness.
    Bergström SH; Järemo H; Nilsson M; Adamo HH; Bergh A
    Prostate; 2018 Mar; 78(4):257-265. PubMed ID: 29250809
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.
    Whitaker HC; Warren AY; Eeles R; Kote-Jarai Z; Neal DE
    Prostate; 2010 Feb; 70(3):333-40. PubMed ID: 19790236
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural and molecular biology of PSP94: Its significance in prostate pathophysiology.
    Anklesaria JH; Mhatre DR; Mahale SD
    Front Biosci (Landmark Ed); 2018 Jan; 23(3):535-562. PubMed ID: 28930560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MSMB variation and prostate cancer risk: clues towards a possible fungal etiology.
    Sutcliffe S; De Marzo AM; Sfanos KS; Laurence M
    Prostate; 2014 May; 74(6):569-78. PubMed ID: 24464504
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.